- New options are emerging for people who are at risk of heart attacks and strokes but can't take or benefit fully from widely used cholesterol drugs.
- A daily pill, bempedoic acid, significantly reduced the risk of heart attacks, strokes and other cardiovascular complications in people intolerant of statins.
- Nexletol and Nexlizet, which combine bempedoic acid with another nonstatin cholesterol-lowering drug, ezetimibe, are on the market.
- Merck & Co. said Monday that it is making progress on a potential new PCSK9 inhibitor.
- Another study showed that an anti-inflammatory drug called colchicine lowered cardiovascular risk in patients on statins with heart disease.
Alternatives to Popular Cholesterol-Lowering Drug Cut Heart-Attack Risk
Three drugs could lower the risk of heart attacks, strokes and other complications for patients who can’t take or benefit enough from statins
Betsy McKay
/cloudfront-us-east-2.images.arcpublishing.com/reuters/RCWZE2OK3BNCJNRVFOS74NYF7M.jpg)
